PubMed Health⌕ Search

Biomedical subjects

H F Loyke

Publications and source records attributed to H F Loyke.

At least 19 recordsLinked to original sources

Cold pressor test as a predictor of the severity of hypertension.

This report examines the cold pressor test (CPT) as it relates to the severity of hypertension. A total of 123 hypertensive patients were studied by physical examination, retinal funduscopy, chest roentgenogram, electrocardiogram, blood urea nitrogen measurement, and urinalysis. Causal and valid basal resting blood pressure determinations were made, followed by immersion of one hand in ice water for 2 minutes. All 21 patients with arteriosclerotic, 78 with essential, and 24 with renal hypertension had hyperreactive responses to the CPT (> 20/20 mm Hg) as compared with the normotensive subjects. The CPT-induced increase in diastolic pressure was significantly higher in hypertensives with left ventricular hypertrophy (LVH). CPT responses were also greater in hypertensives with higher degrees of retinopathy. These findings indicate that the diastolic rise on cold pressor testing can be used as a measure of severity of hypertension, especially in the presence of LVH and severe retinopathy. The CPT is inexpensive and noninvasive and can aid the clinician in managing the hypertensive patient. The CPT may also be useful as a predictor of complications of hypertension in selected individuals.

Adult↗

Copper and zinc in experimental hypertension.

The role of the trace minerals, copper (Cu) and zinc (Zn) are important in maintaining blood pressure. Copper has been found to inhibit the activity of angiotensin's converting enzyme. An interrelationship has been found to exist between Cu and Zn. Data in renal (RH) and spontaneous hypertensive rates (SHR) regarding Cu and Zn is lacking. The purpose of this report was to measure Cu and Zn levels in two types of experimental animal models of hypertension compared to normotensive (NT) rats. Blood samples were drawn to measure serum levels of Cu and Zn in three types of animals, RH, SHR, and NT. Serum Cu values were found to be lower, whereas Zn levels were elevated in the SHR animals. Serum levels of Cu and Zn in the RH animals were similar to those found in the NT animals. Further study of the interaction of those trace minerals is documented, and extends over knowledge of the role of minerals in blood pressure control.

Animals↗

Minerals in renal and SHR hypertensive rats.

References to individual trace minerals in hypertensive rats have been made; however, data on multiple minerals in SHR hypertensive rats is lacking. The purpose of this study was to investigate five trace minerals in normotensive, chronic renal and SHR hypertensive rats. Blood samples were drawn to measure serum levels of Ca, Fe, K, Mg, and Na. Serum K values were elevated in the chronic renal hypertensive animals. Iron levels were decreased in both the renal and SHR hypertensive animals. No difference was observed in levels of Ca, Mg, and Na between normotensive and chronic renal or SHR hypertensive rats. Further study of multiple trace minerals in experimental hypertension is recorded in order to extend these deviations.

Animals↗

The three phases of blood pressure in stroke.

Studies of three large series of hypertensive patients having strokes have shown that systemic blood pressure responds to stroke during the acute phase. The blood pressure is elevated on the day of admission to the hospital in 82% of patients and then decreases to normotensive levels during the subacute stage in 59%. During the chronic phase of stroke, normal blood pressure persists in 26% of these patients. The three phases of blood pressure change after stroke are likely a physiologic response to ischemia of the brain followed by recovery of brain function. The identification of these three states of blood pressure in stroke underlines the importance of prudence and caution in administering antihypertensive drugs to patients who have had a stroke.

Acute Disease↗

Disease states in which blood pressure is lowered.

Hypertension can be ameliorated by certain concomitant disease states, especially those in which serum globulin is elevated. Blood pressure has been reduced in cases of cirrhosis of the liver, chronic alcoholism, congestive heart failure, arthritis, hypothyroidism, and myeloma. These clinical findings were confirmed experimentally when animals with various models of hypertension became normotensive after the development of a modest degree of liver damage with hyperglobulinemia. Other diseases, not associated with hyperglobulinemia, that can lower blood pressure are stroke, uremia, hyperparathyroidism, and malnutrition. When any of these diseases occur in hypertensive patients, their influence on blood pressure must be considered when determining treatment and prognosis.

Animals↗

Demonstration of a depressor substance in serum from CCl4 treated rats.

Previous studies have shown that blood pressure was reduced in rat experimental hypertension following a series of carbon tetrachloride (CCl4) injections. To define this effect more precisely the presently reported experiments were done. Serum from rats treated with CCl4 was injected into various recipients. The mean systolic blood pressure of renal hypertensive recipients decreased significantly at 60 minutes by -15 mm Hg. In normotensive and spontaneous hypertensive rat recipients the pressure did not fall. It is concluded that a vasodepressor substance appears in the serum of CCl4 treated rats which affects only renal hypertensive recipients.

Animals↗

Effect of indomethacin on rats with Grollman hypertension.

Grollman hypertension was produced in 15 Sprague-Dawley rats, and chronic 46-week hypertension was observed in these rats. Weekly subcutaneous injections of 1.44 mg indomethacin resulted in significant reduction of the systolic blood pressure 1 h after the injection (p less than 0.001). There was no change in the blood pressure following treatment with indomethacin in the 6 normotensive control rats. Light microscopic examinations revealed that adrenal and cardiac tissues were free of serious toxic indomethacin effects. Liver tissue examination showed slight degenerative changes in the indomethacin-treated animals.

Adrenal Glands↗

The inhibition of angiotensin converting enzyme in chronic renal hypertension by a synthetic peptide.

Renal hypertension was produced in 14 Sprague-Dawley rats by ligating both poles of one kidney followed in one week by unilateral nephrectomy. Biweekly subcutaneous injections of SQ 20858 reduced the blood pressure in the chronic renal hypertensive animals. Upon discontinuing the injections the blood pressure rose to pretreatment levels. No angiotensin II activity was seen in seven of the renal group treated with SQ indicating a complete block in serum converting enzyme activity. Likewise, serum with only angiotensin I activity when added to normal serum containing converting enzyme, continued to show angiotensin I activity. It is concluded that SQ 20858 is effective in lowering blood pressure in chronic renal hypertensive rats presumably by partially inhibiting converting enzyme.

Angiotensin II↗